Ask AI
ProCE Banner Activity

Frontline Response in Emergency Medicine: Best Practices for Early Recognition and Management of CAR T-Cell and Bispecific Antibody–Related AEs

Slideset

Download these slides from a live webinar with key expert strategies and guideline recommendations for the frontline emergency department on early recognition and management of CAR T-cell and bispecific antibody therapy–related adverse events, including experts’ thoughts on applying these new data into your everyday practice.

Released: February 11, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson

Target Audience

This activity is intended for emergency medicine physicians, nurse practitioners, physician assistants, registered nurses, and pharmacists involved in the care of cancer patients presenting to the emergency department for care. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Develop the ability to recognize the early signs of CRS and ICANS in patients presenting to the emergency department

  • Gain proficiency in the pharmacologic and non-pharmacologic interventions for managing CRS and ICANS

  • Understand the components of REMS and their relevance in the emergency management of CAR-T therapy patients.

  • Enhance collaborative practice skills to improve communication between emergency department staff and oncology teams regarding CAR-T therapy management.

Disclosure

Primary Author

Brian Cameron, MD, has no relevant financial relationships to disclose.

Nathan Shapiro, MD, MPH: consultant/advisor/speaker: AccUrine, Inflammatix, Prenosis.